Marek Kubiszewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marek Kubiszewski has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Elżbieta Urszula Stolarczyk
Spectrometric Methods Department, National Medicines Institute, Warsaw, Poland
5 shared publications - Katarzyna Sidoryk
Chemistry Department, Pharmaceutical Research Institute, 8 Rydygiera Street, 01-793 Warsaw, Poland
3 shared publications - Marcin Cybulski
Chemistry Section, Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network–Industrial Chemistry Institute, 8 Rydygiera Str., 01-793 Warsaw, Poland
3 shared publications - Krzysztof Kuziak
R&D Analytical Chemistry Department, Pharmaceutical Research Institute, 8 Rydygiera Street, 01-793 Warsaw, Poland
2 shared publications - Krzysztof Stolarczyk
Faculty of Chemistry, University of Warsaw, Warsaw, Poland
2 shared publications - Marta Łaszcz
Pharmaceutical Research Institute, Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
Synthesis of Thiol Derivatives of Biological Active Compounds for Nanotechnology Application
An efficient method of thiol group introduction to the structure of common natural products and synthetic active compounds with recognized biological efficacy such genistein (1), 5,11-dimethyl-5H-indolo[2,3-b]quinolin (2), capecitabine (3), diosgenin (4), tigogenin (5), flumethasone (6), fluticasone propionate (7), ursolic acid methyl ester (8), and β-sitosterol (9) was developed. In most cases, the desired compounds were obtained easily via two-step processes involving esterification reaction employing S-trityl protected thioacetic acid and the corresponding hydoxy-derivative, followed by removal of the trityl-protecting group to obtain the final compounds. The results of our preliminary experiments forced us to change the strategy in the case of genistein (1), and the derivatization of diosgenin (4), tigogenin (5), and capecitabine (3) resulted in obtaining different compounds from those designed. Nevertheless, in all above cases we were able to obtain thiol-containing derivatives of selected biological active compounds. Moreover, a modelling study for the two-step thiolation of genistein and some of its derivatives was accomplished using the density functional theory (B3LP). A hypothesis on a possible reason for the unsuccessful deprotection of the thiolated genistein is also presented based on the semiempirical (PM7) calculations. The developed methodology gives access to new sulphur derivatives, which might find a potential therapeutic benefit.
Open AccessSynthesis of Thiol Derivatives of Biological Active Compounds for Nanotechnology Application
An efficient method of thiol group introduction to the structure of common natural products and synthetic active compounds with recognized biological efficacy such genistein (1), 5,11-dimethyl-5H-indolo[2,3-b]quinolin (2), capecitabine (3), diosgenin (4), tigogenin (5), flumethasone (6), fluticasone propionate (7), ursolic acid methyl ester (8), and β-sitosterol (9) was developed. In most cases, the desired compounds were obtained easily via two-step processes involving esterification reaction employing S-trityl protected thioacetic acid and the corresponding hydoxy-derivative, followed by removal of the trityl-protecting group to obtain the final compounds. The results of our preliminary experiments forced us to change the strategy in the case of genistein (1), and the derivatization of diosgenin (4), tigogenin (5), and capecitabine (3) resulted in obtaining different compounds from those designed. Nevertheless, in all above cases we were able to obtain thiol-containing derivatives of selected biological active compounds. Moreover, a modelling study for the two-step thiolation of genistein and some of its derivatives was accomplished using the density functional theory (B3LP). A hypothesis on a possible reason for the unsuccessful deprotection of the thiolated genistein is also presented based on the semiempirical (PM7) calculations. The developed methodology gives access to new sulphur derivatives, which might find a potential therapeutic benefit.
- Open Access
- 7 December 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (12) , 1018
Design of Therapeutic Self-Assembled Monolayers of Thiolated Abiraterone
The aim of our work was to synthetize of a new analogue of abiraterone—thiolated abiraterone (HS-AB) and design a gold surface monolayer, bearing in mind recent advances in tuning monolayer structures and using them as efficient drug delivery systems. Therapeutic self-assembled monolayers (TSAMs) were prepared by chemically attaching HS-AB to gold surfaces. Their properties were studied by voltammetry and atomic force microscopy (AFM). A gold electrode with immobilized thioglycolic acid (HS-GA) was used for comparison. The surface concentration of HS-AB on the gold surface was 0.572 nmol/cm2, determined from the area of the voltammetric reduction peaks (desorption process). The area per one molecule estimated from the voltammetry experiments was 0.291 nmol/cm2. The capacity of thus prepared electrode was also tested. The calculated capacity for the HS-AB modified electrode is 2.90 μF/cm2. The obtained value indicates that the monolayer on the gold electrode is quite well ordered and well-packed. AFM images show the formation of gold nanoparticles as a result of immersing the HS-AB modified gold electrode in an aqueous solution containing 1 mM HAuCl4·3H2O. These structures arise as a result of the interaction between the HS-AB compound adsorbed on the electrode and the AuCl4− ions. The voltammetric experiments also confirm the formation of gold structures with specific catalytic properties in the process of oxygen reduction.
- 7 December 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (12) , 1018
Open AccessDesign of Therapeutic Self-Assembled Monolayers of Thiolated Abiraterone
The aim of our work was to synthetize of a new analogue of abiraterone—thiolated abiraterone (HS-AB) and design a gold surface monolayer, bearing in mind recent advances in tuning monolayer structures and using them as efficient drug delivery systems. Therapeutic self-assembled monolayers (TSAMs) were prepared by chemically attaching HS-AB to gold surfaces. Their properties were studied by voltammetry and atomic force microscopy (AFM). A gold electrode with immobilized thioglycolic acid (HS-GA) was used for comparison. The surface concentration of HS-AB on the gold surface was 0.572 nmol/cm2, determined from the area of the voltammetric reduction peaks (desorption process). The area per one molecule estimated from the voltammetry experiments was 0.291 nmol/cm2. The capacity of thus prepared electrode was also tested. The calculated capacity for the HS-AB modified electrode is 2.90 μF/cm2. The obtained value indicates that the monolayer on the gold electrode is quite well ordered and well-packed. AFM images show the formation of gold nanoparticles as a result of immersing the HS-AB modified gold electrode in an aqueous solution containing 1 mM HAuCl4·3H2O. These structures arise as a result of the interaction between the HS-AB compound adsorbed on the electrode and the AuCl4− ions. The voltammetric experiments also confirm the formation of gold structures with specific catalytic properties in the process of oxygen reduction.
- Open Access
- 22 August 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (9) , 641
Design and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active anticancer substance abiraterone (AB). The direct coupling of AB with gold constitutes an essential feature of the unique AuNPs–AB conjugate that creates a promising platform for applications in nanomedicine. In this work, we present a multidisciplinary, basic study of the obtained AuNPs–AB conjugate. Theoretical modeling based on the density functional theory (DFT) predicted that the Aun clusters would interact with abiraterone preferably at the N-side. A sharp, intense band at 1028 cm−1 was observed in the Raman spectra of the nanoparticles. The shift of this band in comparison to AB itself agrees well with the theoretical model. AB in the nanoparticles was identified by means of electrochemistry and NMR spectroscopy. The sizes of the Au crystallites measured by XRPD were about 9 and 17 nm for the nanoparticles obtained in pH 7.4 and 3.6, respectively. The size of the particles as measured by TEM was 24 and 30 nm for the nanoparticles obtained in pH 7.4 and pH 3.6, respectively. The DLS measurements revealed stable, negatively charged nanoparticles.
- 22 August 2018
- Published by MDPI AG in Nanomaterials
- Vol. 8 (9) , 641
Open AccessDesign and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active anticancer substance abiraterone (AB). The direct coupling of AB with gold constitutes an essential feature of the unique AuNPs–AB conjugate that creates a promising platform for applications in nanomedicine. In this work, we present a multidisciplinary, basic study of the obtained AuNPs–AB conjugate. Theoretical modeling based on the density functional theory (DFT) predicted that the Aun clusters would interact with abiraterone preferably at the N-side. A sharp, intense band at 1028 cm−1 was observed in the Raman spectra of the nanoparticles. The shift of this band in comparison to AB itself agrees well with the theoretical model. AB in the nanoparticles was identified by means of electrochemistry and NMR spectroscopy. The sizes of the Au crystallites measured by XRPD were about 9 and 17 nm for the nanoparticles obtained in pH 7.4 and 3.6, respectively. The size of the particles as measured by TEM was 24 and 30 nm for the nanoparticles obtained in pH 7.4 and pH 3.6, respectively. The DLS measurements revealed stable, negatively charged nanoparticles.
- Open Access
- 7 March 2016
- Published by PeerJ in PeerJ Preprints
Synthesis and analytical characterization of gold nanoparticles for anticancer drug delivery application
For many years research has been carried out to form selective drug carriers. Gold nanoparticles (AuNP) are of particular interest. New perspectives of these nanoparticles as drug carries include: the use of drugs which are poorly soluble in water, targeted delivery of drugs, transport by barrier membranes, the possibility of macromolecular drug release, "combined" treatment - two or more drugs, securing faster mechanisms of action and improved efficiency of drugs. Drug-modified gold nanoparticles (R-AuNP) have been synthesized in a single-phase system based on the reduction of hydrogen tetrachloroaurate (III) using the stabilizing ligand. The color change from yellow to deep ruby red indicated the formation of gold nanoparticles. The formation of stabilized gold nanoparticles was confirmed by the observation of the surface plasmon resonance band. Varying drug concentrations and kinds of solvents were used for the reduction of tetrachloroaurate to determine the effect of drug/ligand concentration and solvent type on the formation of AuNPs. The stability of newly synthesized R-AuNPs was characterized using UV-Vis spectroscopy. The conjugated particles (the resulting AuNPs) were characterized by several techniques, including transmission electron microscopy (TEM), UV-Vis spectroscopy, infrared spectroscopy (IR), Raman spectroscopy, nuclear magnetic resonance spectroscopy (NMR), capillary electrophoresis, electrochemical techniques and zeta potential measurement. In any application of the AuNPs, it is important first to determine their basic physico-chemical characteristics, such as, e.g. size, shape, mono- or polydispersity, UV–Vis spectra, electrokinetic potential as well as other special parameters and analytical methods employed in the characterization of the AuNPs. TEM is a powerful and straightforward method for the determination of size (including size distribution) and shape of the AuNPs. UV–Vis absorption spectrophotometry allows for an in situ direct analysis of colloidal solutions. The position of the observed band maxima (typically in the range 500 – 600 nm) is usually related to particle size. However, the position of the surface-plasmon resonance (SPR) maximum cannot be directly related to the particle size of the NPs and other factors have to be considered. The capillary electrophoresis is the method applied to confirm the formation of nanoparticles as well as to determine the drug residuals in the leachate during the purification of the conjugates. By means of infrared and Raman spectroscopy it is possible to study the molecular species deposited on the AuNPs. The NMR spectroscopy and electrochemical techniques are used to confirm the attached drugs. Complete structural characterization of the organic molecules attached to the AuNPs surface was carried out.
- 7 March 2016
- Published by PeerJ in PeerJ Preprints
Open AccessSynthesis and analytical characterization of gold nanoparticles for anticancer drug delivery application
For many years research has been carried out to form selective drug carriers. Gold nanoparticles (AuNP) are of particular interest. New perspectives of these nanoparticles as drug carries include: the use of drugs which are poorly soluble in water, targeted delivery of drugs, transport by barrier membranes, the possibility of macromolecular drug release, "combined" treatment - two or more drugs, securing faster mechanisms of action and improved efficiency of drugs. Drug-modified gold nanoparticles (R-AuNP) have been synthesized in a single-phase system based on the reduction of hydrogen tetrachloroaurate (III) using the stabilizing ligand. The color change from yellow to deep ruby red indicated the formation of gold nanoparticles. The formation of stabilized gold nanoparticles was confirmed by the observation of the surface plasmon resonance band. Varying drug concentrations and kinds of solvents were used for the reduction of tetrachloroaurate to determine the effect of drug/ligand concentration and solvent type on the formation of AuNPs. The stability of newly synthesized R-AuNPs was characterized using UV-Vis spectroscopy. The conjugated particles (the resulting AuNPs) were characterized by several techniques, including transmission electron microscopy (TEM), UV-Vis spectroscopy, infrared spectroscopy (IR), Raman spectroscopy, nuclear magnetic resonance spectroscopy (NMR), capillary electrophoresis, electrochemical techniques and zeta potential measurement. In any application of the AuNPs, it is important first to determine their basic physico-chemical characteristics, such as, e.g. size, shape, mono- or polydispersity, UV–Vis spectra, electrokinetic potential as well as other special parameters and analytical methods employed in the characterization of the AuNPs. TEM is a powerful and straightforward method for the determination of size (including size distribution) and shape of the AuNPs. UV–Vis absorption spectrophotometry allows for an in situ direct analysis of colloidal solutions. The position of the observed band maxima (typically in the range 500 – 600 nm) is usually related to particle size. However, the position of the surface-plasmon resonance (SPR) maximum cannot be directly related to the particle size of the NPs and other factors have to be considered. The capillary electrophoresis is the method applied to confirm the formation of nanoparticles as well as to determine the drug residuals in the leachate during the purification of the conjugates. By means of infrared and Raman spectroscopy it is possible to study the molecular species deposited on the AuNPs. The NMR spectroscopy and electrochemical techniques are used to confirm the attached drugs. Complete structural characterization of the organic molecules attached to the AuNPs surface was carried out.
- Open Access
Identification and Physicochemical Characteristics of Temozolomide Process-Related Impurities
In this article the crystal structures of the starting material TZ-5 and the key intermediate TZ-6 of temozolomide (TZ-7), an anticancer therapeutic agent, are presented, together with their spectroscopic and thermal characteristics. Both compounds crystallize in the triclinic P-1 space group. X-ray crystallography studies proved that the compound TZ-6 exists as a monohydrate. A complete structural assignment was obtained for the signals in the 1H-, 13C- and 15N-nuclear magnetic resonance spectra and the structures were confirmed by Fourier-Transform infrared and Raman spectroscopy. The article describes the importance of the high purity of TZ-6 during the small-scale plant production of TZ-7 in a desired polymorphic form III with the purity higher than 99.50%, according to an HPLC method.
Open AccessIdentification and Physicochemical Characteristics of Temozolomide Process-Related Impurities
In this article the crystal structures of the starting material TZ-5 and the key intermediate TZ-6 of temozolomide (TZ-7), an anticancer therapeutic agent, are presented, together with their spectroscopic and thermal characteristics. Both compounds crystallize in the triclinic P-1 space group. X-ray crystallography studies proved that the compound TZ-6 exists as a monohydrate. A complete structural assignment was obtained for the signals in the 1H-, 13C- and 15N-nuclear magnetic resonance spectra and the structures were confirmed by Fourier-Transform infrared and Raman spectroscopy. The article describes the importance of the high purity of TZ-6 during the small-scale plant production of TZ-7 in a desired polymorphic form III with the purity higher than 99.50%, according to an HPLC method.